More than 11,500 patients have benefited from Eastern AHSN-supported projects in six months, with one programme alone saving the NHS an estimated £1.1million.
The Electronic Medication Optimization Pathway (EMOP) has led to a reduction in patient re-admissions rates, which has freed up much-needed hospital bed capacity and led to substantial savings. EMOP is one of a number of national improvement and innovation programmes which are being adopted locally with the support of Eastern AHSN.
Since the launch of the national programmes in April, the team has worked with police services, 280 GP practices, 16 acute trusts, 16 clinical commissioning groups (CCGs) and six sustainability and transformation partnerships (STPs). To date, over 11,500 patients have benefitted from these new and improved services.
Highlights from the first six months include:
- Launch of Serenity Integrated Monitoring (SIM) programme, bringing healthcare and policing together to make a positive difference to the lives of patients with complex mental health needs, and their families. SIM is live in one trust already with conversations on adoption taking place with three more organisations.
- PreCept – magnesium sulphate injection that reduces the risk of babies being born with cerebral palsy by up to 30%. Eastern AHSN has now agreed plans with all its local maternity units to support the adoption of PReCept over the next 18 months, with the team supporting clinical backfill and regional shared learning.
- EMOP – a medicine discharge service that aims to reduce readmissions by helping patients to stay on the correct medication on discharge from hospital. EMOP is now live in four sites with plans for three more to go live in the first three months of 2019. Read one of our patient case studies.
- Escape-Pain – a six-week National Institute for Health and Care Excellence-approved programme providing group rehabilitation for patients with chronic joint pain. Since April, Eastern AHSN has supported three new areas to adopt the programme.
- ITP – Eastern AHSN has supported local adoption of multiple products from the national Innovation and Technology Payment The region has exceeded planned levels of adoption for both Endocuff and Urolift already this year with 5,893 people benefitting from the new technologies.